Rivvi

Conversational AI infrastructure for healthcare.

Website: https://rivvi.ai/

Cover Block

PUBLIC

Field Value
Name Rivvi
Tagline Conversational AI infrastructure for healthcare
Headquarters Boston, Massachusetts
Founded 2024
Business Model SaaS
Industry Healthtech
Technology Type AI / Machine Learning (conversational, voice and text)
Geography North America
Growth Profile Venture Scale
Founding Team Solo Founder (Nathan Hayman)

Links

PUBLIC

Executive Summary

PUBLIC

Rivvi is a Boston-based healthcare AI company building conversational infrastructure that lets health systems, payers, pharmacies, life sciences companies, and government agencies reach patients at scale via voice, text, and other digital channels [Rivvi]. The company was founded in 2024 by Nathan Hayman, who serves as Founder and CEO and whose public profile describes a background in digital innovation and healthcare technology [LinkedIn]. The product positions itself as the platform layer between fragmented patient data and patient-facing conversations, with HIPAA and TCPA compliance baked into the terms of service that govern customer use [Rivvi]. Company-reported usage figures cite more than two million automated patient interactions and over 500,000 patients reached, alongside a claim of 40:1 team use [Rivvi]. The competitive frame is unusual: Rivvi sits adjacent to traditional payer infrastructure (UnitedHealthcare), AI claims processors (Vitraya), and integrated provider plays (Ayu Health), without directly overlapping any of them. Funding, investor syndicate, and revenue are not publicly disclosed at the time of writing, which puts the company squarely in early-stage territory and makes the next 12 to 18 months a window in which a priced round or a named anchor health-system customer would meaningfully de-risk the story. For investors, the watch items are simple: who funds the first institutional round, and which of the named verticals (payers, health systems, pharmacies) converts first into a referenceable contract.

Data Accuracy: YELLOW -- Confirmed by Rivvi primary sources and LinkedIn; funding and revenue not independently verified.

Taxonomy Snapshot

Axis Value
Business Model SaaS
Industry / Vertical Healthtech, patient engagement
Technology Type Conversational AI (voice + text)
Geography North America
Growth Profile Venture Scale
Founding Team Solo Founder

Company Overview

PUBLIC

Rivvi was incorporated in 2024 and operates under the legal name Rivvi AI, Inc., per the copyright notice on its public site [Rivvi]. The company describes its mission in plain terms on its About page: "After automating over 2 million patient interactions, we've learned one truth: the healthcare workforce wants to help, they just need better tools. We're building the AI infrastructure that enables care teams to reach every patient who needs them" [Rivvi]. The Boston headquarters is the registered base of operations, although founder Nathan Hayman's LinkedIn profile lists him as based in the Atlanta Metropolitan Area, suggesting a distributed team posture from inception [LinkedIn].

The public milestone trail is thin, which is consistent with a company roughly a year into operation. The earliest dated artifact captured in research is a July 2025 technical blog comparing voice AI economics to traditional call centers for Medicare outreach, which positioned Rivvi against a benchmark cost of $5.63 per successful live-agent conversation [Rivvi, July 2025]. The company has also published a case study claiming a 56 percent success rate on a patient engagement deployment, although the customer is not named in the public version of the study [Rivvi]. A careers page is live and indicates the company is "growing fast and creating new positions regularly," although no specific roles were captured at the time of research [Rivvi].

Third-party databases including Crunchbase, Tracxn, and the IAmsterdam and Milano startup maps list Rivvi but do not surface confirmed funding rounds or investors [Crunchbase] [Tracxn] [IAmsterdam]. Capitalization is not publicly disclosed; investors should request the cap table directly.

Data Accuracy: YELLOW -- Confirmed by Rivvi primary sources, Crunchbase, and Tracxn; corporate filings not independently pulled.

Product and Technology

MIXED

Rivvi sells what it calls conversational AI infrastructure, which in practice means a platform that orchestrates outbound and inbound patient communication across voice and text, with safety, governance, and intelligence layers branded internally as "Aegis" and surfaced in the site navigation [Rivvi]. The company markets distinct vertical entry points for health systems, payers, pharmacies, government, and life sciences, with the payer page emphasizing Medicare Stars improvement, quality-gap closure, and member-outcome lift as the primary value props [Rivvi]. The terms of service explicitly bind customers to HIPAA and TCPA compliance when using the platform to reach patients, which is the table-stakes regulatory posture for any vendor touching protected health information and outbound dialing in the United States [Rivvi].

The technical positioning, as articulated in Rivvi's own July 2025 blog, leans on a cost argument: a single successful conversation with a live agent is cited at $5.63, against an automated voice AI call at "a fraction of that" [Rivvi, July 2025]. The published case study claims a 56 percent success rate on engagement, framed as the output of "intelligent orchestration" that treats patients as individuals with unique preferences rather than a single broadcast list [Rivvi]. The underlying model stack, whether Rivvi runs proprietary speech models, fine-tunes an open-weights base, or orchestrates third-party foundation models behind a healthcare-specific policy layer, is not disclosed in public materials.

Differentiation, as far as the public surface area allows one to judge, rests on the regulatory wrapper (HIPAA and TCPA enforcement at the platform level), the verticalized go-to-market across five named healthcare buyer segments, and the orchestration layer that routes patients through multi-channel sequences rather than single-shot calls [Rivvi]. What is not yet visible is the proprietary dataset, the integration depth with EHR systems such as Epic or Cerner, or any partnership with a named health system that would convert the product story into a reference-customer story.

Data Accuracy: ORANGE -- Confirmed by Rivvi primary sources only; no independent technical review or customer reference captured.

Market Research and Opportunity

PUBLIC

Patient engagement is one of the few healthcare software categories where the buyer pain (rising labor costs, Stars-rating pressure on payers, persistent no-show and quality-gap economics) is being met by a step-change improvement in the underlying technology (production-grade voice AI). That collision is what makes the category interesting in 2025.

No named third-party TAM report was captured in the research for the patient-engagement-AI segment specifically, so investors should treat sizing as triangulated rather than sourced. The most directly relevant public data point captured is Rivvi's own benchmark on the unit economics of incumbent workflows: $5.63 per successful live-agent conversation for Medicare outreach [Rivvi, July 2025]. Multiplied across the roughly 65 million Medicare beneficiaries and the multi-touch outreach cadence required for Stars measures, the substitutable spend on outbound member contact alone runs into the low billions annually (estimated). Adjacent buyers (health systems running appointment reminders and pre-visit prep, pharmacies running adherence outreach, life sciences running patient support programs) expand the addressable surface meaningfully.

Demand drivers visible in the cited material are concrete. Payers face direct revenue exposure to Medicare Stars ratings, which Rivvi explicitly targets on its payer page [Rivvi]. Health systems face a workforce shortage that the company frames as the central justification for its mission: care teams "want to help, they just need better tools" [Rivvi]. Regulatory tailwinds cut both ways. HIPAA and TCPA raise the bar for any vendor handling outbound patient contact, which favors compliance-native platforms over general-purpose voice AI tools, but the same regimes also constrain how aggressively any vendor can scale outbound volume.

Reference point Figure Source
Cost per successful live-agent Medicare conversation $5.63 [Rivvi, July 2025]
Rivvi-reported patient interactions automated 2,000,000+ [Rivvi]
Rivvi-reported patients reached 500,000+ [Rivvi]

The unit-economics gap between a $5.63 live conversation and an automated equivalent is the single clearest reason a payer or health system would write a check, and it is also the reason this category will attract well-capitalized competitors quickly.

Data Accuracy: ORANGE -- Cost benchmark sourced to Rivvi's own blog; no independent third-party TAM report captured.

Competitive Landscape

MIXED

Company Positioning Stage / Funding Notable Differentiator Source
Rivvi Conversational AI infrastructure for healthcare, voice and text, vertical-specific Early stage, funding undisclosed HIPAA and TCPA compliance at the platform layer; multi-vertical go-to-market [Rivvi]
UnitedHealthcare National payer with internal member-engagement operations Public (UNH parent) Owns the member relationship and internal call-center capacity at scale
Vitraya AI for health insurance claims adjudication Private, funded Claims-side automation rather than patient-facing engagement
Ayu Health Hospital network operator (India) Private, funded Vertically integrated provider model; geography is non-overlapping

The segment map breaks down cleanly. On the incumbent side sit national payers like UnitedHealthcare that run member outreach in-house through large captive call centers; the threat to Rivvi here is not displacement but procurement (the largest payers may build rather than buy, or restrict third-party access to member data). On the adjacent-AI side sit companies like Vitraya, which apply machine learning to a different part of the healthcare value chain (claims rather than conversations); these are not direct competitors today but will increasingly compete for the same buyer attention and IT budget. Vertically integrated provider plays like Ayu Health are a reminder that in some geographies the engagement layer is owned by the operator rather than sold as software.

Where Rivvi has a defensible edge today is the combination of healthcare-specific compliance posture (HIPAA and TCPA written into the terms of service rather than bolted on) and a multi-vertical wedge that lets the company sell into payers, providers, pharmacies, and life sciences without rebuilding the core orchestration engine [Rivvi]. That edge is real but perishable. The compliance moat narrows as horizontal voice AI vendors invest in healthcare overlays, and the multi-vertical pitch only converts into durable advantage if Rivvi accumulates proprietary outcome data across deployments faster than single-vertical specialists.

The most exposed flank is the absence of a named anchor customer in public materials. Competing patient-engagement platforms with named health-system or payer logos can convert a sales conversation in two meetings; Rivvi currently cannot, based on the public surface. The most plausible 18-month scenario: winner if Rivvi lands a named Medicare Advantage payer reference and uses the Stars-rating outcome to pull in two or three more, building a payer-centric moat before horizontal voice AI vendors verticalize; loser if a well-capitalized horizontal competitor (or an EHR-embedded incumbent) ships a HIPAA-compliant voice product with native Epic or Cerner integration, collapsing the differentiation to price.

Opportunity

PUBLIC

If Rivvi executes against the wedge it has chosen, the prize is the default conversational layer between American healthcare organizations and their patients, a category with no clear winner today.

The single largest outcome Rivvi could plausibly become is the API-shaped infrastructure that every payer, health system, and pharmacy uses to talk to patients, in the same way that Twilio became the default for general-purpose messaging but with healthcare-specific compliance, orchestration, and outcome measurement built in. The cited evidence that this outcome is reachable rather than aspirational: the unit-economics gap is large and durable ($5.63 per live conversation versus a fraction of that automated, per Rivvi's own benchmark) [Rivvi, July 2025]; the buyer set is concentrated (a few dozen national payers and integrated delivery networks account for most of the addressable spend); and the regulatory perimeter (HIPAA, TCPA) raises the floor on what general-purpose AI vendors can ship without a healthcare-specific wrapper [Rivvi].

Growth scenarios.

Scenario What happens Catalyst Why it's plausible
Payer Stars play Rivvi becomes the de facto outreach engine for Medicare Advantage Stars-rating improvement A named MA payer publishes a Stars lift attributed to Rivvi Stars ratings drive direct payer revenue; the payer page is already targeted at this use case [Rivvi]
Health-system workforce relief Rivvi sells into hospital systems as a workforce-multiplier for appointment, pre-visit, and follow-up outreach A reference deployment at a top-50 IDN with a published outcome metric The 56 percent success rate case study is already templated for this motion [Rivvi]
Pharma patient support API Life sciences companies embed Rivvi as the conversation layer in branded patient support programs A pharma manufacturer signs a multi-brand master agreement Markets page already names life sciences as a target vertical [Rivvi]

What compounding looks like. The flywheel that turns one win into the next is outcome data. Each deployment generates a labeled corpus of patient-response patterns by demographic, condition, and channel that horizontal voice AI vendors cannot easily replicate without HIPAA-compliant access. Over time, that corpus improves message routing, channel selection, and timing in ways that show up as higher success rates per dollar spent, which is the metric payers and health systems actually buy on. The company-reported figures (2 million interactions, 500,000 patients reached) are early evidence that the corpus is accumulating, although the absence of independent verification means investors should treat them as directional rather than audited [Rivvi].

The size of the win. A useful comparable, although not a forecast, is the public market valuation of category-defining healthcare workflow platforms; companies that successfully embed themselves as the default communication or workflow layer for payers and providers have historically traded at high revenue multiples once recurring contracts and net retention are visible. If Rivvi captures even a low-single-digit percentage of US payer and health-system outreach spend in the payer Stars scenario above, the resulting revenue base would support a valuation in the high hundreds of millions to low billions of dollars (scenario, not a forecast). The qualifier is critical: nothing in the currently public dataset confirms the revenue, contract structure, or net retention that would underwrite that outcome, and the next funding announcement will be the first hard datapoint in that direction.

Data Accuracy: ORANGE -- Scenarios constructed from cited Rivvi product positioning; no third-party financial benchmarks captured for direct comparables.

Sources

PUBLIC

  1. [Rivvi] Conversational AI Infrastructure for Healthcare | https://rivvi.ai/

  2. [Rivvi] AI Patient Engagement for Health Systems | https://rivvi.ai/markets/health-systems

  3. [Rivvi] About Our Healthcare AI Company | https://rivvi.ai/company

  4. [Rivvi] About Rivvi - Healthcare AI Company | https://rivvi.ai/company/about

  5. [Rivvi] AI Solutions for Health Plan Payers | https://rivvi.ai/markets/payers

  6. [Rivvi] Terms of Service - Rivvi AI Platform | https://rivvi.ai/legal/terms

  7. [Rivvi] Privacy Policy | https://rivvi.ai/legal/privacy

  8. [Rivvi] Patient Engagement Platform: 56% Success Rate | https://rivvi.ai/resources/case-studies/patient-engagement-platform-56-percent-success

  9. [Rivvi, July 2025] Voice AI vs. Call Centers for Medicare Outreach | https://rivvi.ai/resources/blog/ai-patient-communication

  10. [Rivvi] Careers - Build AI That Helps Patients | https://rivvi.ai/company/careers

  11. [Rivvi] Press & Media Resources | https://rivvi.ai/resources/press

  12. [LinkedIn] Nathan H. - Founder & CEO @ Rivvi | https://www.linkedin.com/in/nathanhayman/

  13. [Crunchbase] Rivvi - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/rivvi-cd86

  14. [Tracxn] Rivvi - 2026 Company Profile, Team & Competitors | https://tracxn.com/d/companies/rivvi/__NO9JnWeCMYzxlsEKMWAbXr4IfahP-rb9pxPTnVt7Sg8

  15. [IAmsterdam] Rivvi company information, funding & investors | https://startupmap.iamsterdam.com/companies/rivvi_1

Articles about Rivvi

View on Startuply.vc